How to Get Jatenzo in Oklahoma: Telehealth, Prescriptions, and Pharmacy Access

How to Get Jatenzo in Oklahoma
At a glance
- Generic name / oral testosterone undecanoate (TU), brand Jatenzo
- Manufacturer / Tolmar Pharmaceuticals
- Dose form / oral capsule, taken twice daily with food
- Oklahoma telehealth prescribing / permitted under state law
- Prescriber types / MD, DO, NP (with prescriptive authority), PA
- Oklahoma Medicaid / not covered for Jatenzo
- 503A compounding / available and licensed to ship within Oklahoma
- Lab minimum / two fasting morning total testosterone levels plus CBC, CMP
- FDA approval basis / Swerdloff et al. 2020 registration trial
- DEA schedule / Schedule III controlled substance
Why Jatenzo Matters for Oklahoma TRT Patients
Jatenzo became the first FDA-approved oral testosterone undecanoate capsule in March 2019, giving men with hypogonadism an alternative to injections and topical gels. The key registration trial by Swerdloff et al. (2020) enrolled 166 hypogonadal men and demonstrated that 87% of participants achieved a eugonadal total testosterone range of 300 to 1 to 100 ng/dL at day 90 on the 237 mg twice-daily dose. That oral route removes the need for intramuscular injections every one to two weeks, a meaningful advantage for men who travel across rural parts of the state or lack easy access to a clinic for supervised injections.
Oklahoma ranks 43rd nationally in physician density per capita, according to AAMC workforce data, which makes telehealth prescribing especially relevant. The state's Telehealth Act permits initial prescriber-patient relationships to be established via synchronous audio-video visits, and controlled substances in Schedule III (which includes testosterone products) can be prescribed remotely once a valid relationship exists.
Step 1: Confirm a Clinical Diagnosis of Hypogonadism
Before any prescriber in Oklahoma will write a Jatenzo prescription, you need a confirmed diagnosis of male hypogonadism. The Endocrine Society Clinical Practice Guideline (2018) requires two separate fasting morning blood draws showing total testosterone below 300 ng/dL, collected between 7:00 and 10:00 a.m. A single low reading is not sufficient.
Required baseline labs typically include:
- Total testosterone (two draws on separate days, fasting, before 10 a.m.)
- Free testosterone or SHBG to clarify borderline total T values
- Complete blood count (CBC) to establish baseline hematocrit
- Comprehensive metabolic panel (CMP) including liver enzymes (AST/ALT)
- PSA for men over age 40
- LH and FSH to distinguish primary from secondary hypogonadism
The Endocrine Society guideline explicitly recommends against testosterone therapy in men planning fertility, since exogenous testosterone suppresses spermatogenesis through HPG axis negative feedback. Your prescriber should ask about fertility goals during the initial visit.
Labs can be drawn at any Quest Diagnostics or LabCorp location in Oklahoma. Oklahoma City, Tulsa, Norman, and Lawton each have multiple draw sites. For rural counties, mobile phlebotomy services or hospital-affiliated outpatient labs are options.
Step 2: Choose a Prescriber (Telehealth or In-Person)
Oklahoma law allows MDs, DOs, nurse practitioners with full prescriptive authority, and physician assistants to prescribe Schedule III controlled substances, including Jatenzo. The Oklahoma Medical Board and Oklahoma Board of Nursing both recognize telehealth as a valid modality for establishing prescriber-patient relationships.
Three prescriber pathways exist:
In-person endocrinologist or urologist. Oklahoma has roughly 85 board-certified endocrinologists statewide, concentrated in Oklahoma City and Tulsa metro areas. Wait times for new endocrinology consults average four to eight weeks.
Primary care provider. Family medicine physicians and internists in Oklahoma can prescribe Jatenzo. This is often the fastest route for men in smaller cities like Edmond, Broken Arrow, or Stillwater.
Telehealth platform. Licensed telehealth providers operating in Oklahoma can prescribe Jatenzo after a synchronous video consultation and lab review. The prescriber must hold an active Oklahoma medical license or be practicing under an interstate compact that covers the state. Oklahoma joined the Interstate Medical Licensure Compact in 2017, broadening the pool of available telehealth clinicians.
A telehealth visit typically takes 20 to 35 minutes for the initial evaluation, including symptom review, lab interpretation, and discussion of treatment options.
Step 3: Understand Oklahoma Pharmacy and Dispensing Options
Once your prescriber submits the Jatenzo prescription electronically (EPCS is required for Schedule III substances in Oklahoma as of 2023), you have several pharmacy pathways.
Retail pharmacy. CVS, Walgreens, and independent pharmacies in Oklahoma can order brand Jatenzo from wholesale distributors. Stock is not always on the shelf, so calling ahead to confirm availability saves time. Typical turnaround from order to pickup is two to four business days if the pharmacy needs to special-order the capsules.
Specialty pharmacy. Some insurers mandate use of a specialty pharmacy for Jatenzo. Accredo, AllianceRx Walgreens, and OptumRx are the most common specialty pharmacies used by Oklahoma-based plans. These ship directly to your home, often with cold-chain packaging where required.
503A compounding pharmacy. Oklahoma-licensed 503A compounding pharmacies can prepare oral testosterone undecanoate capsules under a patient-specific prescription. The Oklahoma State Board of Pharmacy oversees compounding licensure, and 503A pharmacies in the state are authorized to ship compounded prescriptions to patients within Oklahoma. Compounded TU capsules typically cost 40% to 60% less than brand Jatenzo, though bioequivalence with the branded product has not been established in FDA-reviewed trials.
Prior Authorization: What Oklahoma Insurers Require
Most commercial plans in Oklahoma (Blue Cross Blue Shield of Oklahoma, CommunityCare, GlobalHealth) classify Jatenzo as a non-preferred brand requiring prior authorization. The documentation package your prescriber will need to submit generally includes:
- Two lab-confirmed morning testosterone levels below 300 ng/dL
- Documentation of the clinical diagnosis (ICD-10 code E29.1 for primary or E23.0 for secondary hypogonadism)
- Evidence that the patient has tried or cannot tolerate at least one topical or injectable testosterone formulation (step therapy requirement)
- Current CBC with hematocrit below 50%
- PSA result for men aged 40 and older
Oklahoma Medicaid (SoonerCare) does not cover brand Jatenzo. Men enrolled in SoonerCare who need TRT are generally limited to generic testosterone cypionate injections or topical formulations on the preferred drug list. Appeals for Jatenzo coverage through SoonerCare have a low approval rate based on available prior authorization data.
The average prior authorization turnaround for commercial insurers in Oklahoma is three to seven business days. The Endocrine Society's position statement on testosterone therapy supports coverage of FDA-approved testosterone formulations for diagnosed hypogonadism, which can strengthen appeal letters if an initial PA is denied.
Jatenzo Dosing, Safety Monitoring, and Follow-Up
The FDA-approved prescribing information for Jatenzo specifies a starting dose of 237 mg taken orally twice daily with food. Food increases absorption by approximately 2- to 5-fold compared to the fasted state, so taking capsules with a meal containing at least 15 to 20 grams of fat is clinically important.
Dose adjustments follow a structured schedule:
| Timepoint | Action | |---|---| | Baseline | Start 237 mg BID with food | | Week 3, 6 | Check trough total T; adjust to 158 mg, 198 mg, or 316 mg BID | | Month 3 | Repeat total T, CBC (hematocrit), hepatic panel | | Every 6 to 12 months | Ongoing total T, CBC, PSA (if indicated), lipid panel |
In the Swerdloff registration trial, the most common adverse effects were headache (5.4%), nausea (4.2%), and increased hematocrit (3.6%). Hematocrit monitoring is non-negotiable. The Endocrine Society guideline recommends withholding testosterone if hematocrit exceeds 54%, due to increased thromboembolic risk.
The FDA label also carries a warning about increased blood pressure. In the registration study, mean systolic blood pressure rose 3 to 5 mmHg from baseline in the Jatenzo arm. Men with uncontrolled hypertension (systolic >140 mmHg on repeated measurement) should have blood pressure stabilized before starting therapy.
Cost of Jatenzo in Oklahoma Without Insurance
Brand Jatenzo carries a wholesale acquisition cost (WAC) of approximately $580 to $650 per month for the 237 mg twice-daily regimen. Cash prices at Oklahoma retail pharmacies range from $550 to $750 per month depending on the pharmacy and any manufacturer copay card applied.
Tolmar offers a savings program that can reduce out-of-pocket cost to as low as $50 per month for commercially insured patients. Patients paying full cash price may benefit from comparing GoodRx or RxSaver discount pricing across Oklahoma pharmacies, as pricing varies significantly between chains and independents.
Compounded oral testosterone undecanoate from a 503A pharmacy in Oklahoma typically costs $120 to $250 per month, though patients should discuss with their prescriber whether a compounded product meets their clinical needs.
Transferring a Jatenzo Prescription to Oklahoma
If you are relocating to Oklahoma with an existing Jatenzo prescription from another state, the process depends on your prescriber's licensure. An out-of-state prescriber cannot write new prescriptions for Oklahoma patients unless they hold an Oklahoma license or practice under the Interstate Medical Licensure Compact. Your options:
- Prescription transfer. Oklahoma pharmacies can accept a transferred Schedule III prescription from an out-of-state pharmacy for any remaining refills. Contact the receiving Oklahoma pharmacy and provide your current pharmacy's information.
- New prescriber. Establish care with an Oklahoma-licensed prescriber (in-person or telehealth) who can review your prior labs and continue therapy. If your most recent labs are within 90 days, many prescribers will accept them without requiring new draws.
- Telehealth continuity. If your current telehealth provider is licensed in Oklahoma, no change is needed.
Controlled Substance Regulations Specific to Oklahoma
Jatenzo is a Schedule III controlled substance under both federal law and Oklahoma's Uniform Controlled Dangerous Substances Act. Key state-specific rules:
- Prescriptions are valid for six months from the date written, with up to five refills permitted within that window per Oklahoma Pharmacy Board rules.
- Electronic prescribing (EPCS) is the default for controlled substances. Paper prescriptions require specific exemption documentation.
- Oklahoma's Prescription Monitoring Program (PMP) requires prescribers to check the PMP before issuing a new Schedule III prescription. This check is automated in most EHR systems.
Timeline: From First Lab Draw to First Dose
A realistic timeline for a new Jatenzo patient in Oklahoma:
| Step | Typical Duration | |---|---| | Lab draw and results | 2 to 5 days | | Second confirmatory lab draw | 7 to 14 days after first | | Telehealth or in-person visit | 1 to 7 days after labs | | Prior authorization (if needed) | 3, 7 business days | | Pharmacy fill and pickup/delivery | 2 to 4 days | | Total | 15 to 37 days |
Men using telehealth and paying cash (bypassing prior authorization) can compress this timeline to roughly 10 to 14 days from first blood draw to first capsule.
Frequently asked questions
›How do I get a Jatenzo prescription in Oklahoma?
›What labs are needed before Jatenzo in Oklahoma?
›Are there telehealth providers in Oklahoma prescribing Jatenzo?
›How long until I receive Jatenzo in Oklahoma?
›Can I transfer a Jatenzo prescription to Oklahoma?
›Are 503A pharmacies in Oklahoma licensed to ship oral testosterone undecanoate?
›Who can prescribe Jatenzo in Oklahoma (MD vs NP vs PA)?
›What documentation does prior authorization require in Oklahoma?
›Does Oklahoma Medicaid cover Jatenzo?
›What is the starting dose of Jatenzo?
›Can I take Jatenzo without food?
›Is Jatenzo the same as injectable testosterone?
References
- Swerdloff RS, Wang C, White WB, et al. A new oral testosterone undecanoate formulation restores testosterone to normal concentrations in hypogonadal men. J Clin Endocrinol Metab. 2020;105(8):2515-2531. https://pubmed.ncbi.nlm.nih.gov/31773132/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- U.S. Food and Drug Administration. Jatenzo (testosterone undecanoate) prescribing information. https://www.accessdata.fda.gov/
- Endocrine Society. Testosterone therapy in adult men with androgen deficiency syndromes. https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy
- Association of American Medical Colleges. 2024 state physician workforce data report. https://www.aamc.org/